Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
51 results about "Salvianolic acid T" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Salvianolic acid T (1) was isolated as yellowish amorphous powder and showed [α] D 25 + 196.6 (c = 0.25, MeOH), it was recognized as a phenolic acid from a positive test with ferric trichloride and bromocresol green.
Method for preparing salvianolic acid A by catalytically converting salvianolic acid B
InactiveCN102212004AShorten the timeHigh yieldOrganic compound preparationCarboxylic acid esters preparationSalvianolic acid KSalvianolic acid B
The invention discloses a method for preparing salvianolic acid A by catalytically converting salvianolic acid B. The method is characterized in that the converted raw material is a salvia miltiorrhiza aqueous extract (salvianolic acid B=>50%) primarily purified through combined chromatography; the concentration of the raw material salvianolic acid B is 0.5-2%; urea is taken as the catalyst; the mole ratio of urea to the salvianolic acid B is 0.3-0.7; the conversion reaction temperature is 100-125 DEG C; and the reaction time is 3-6 hours. The method has the following beneficial effects: urea is taken as the catalyst, thus greatly shortening the time for which the salvianolic acid B is in easily destroyed state and remarkably increasing the yield of the salvianolic acid A; the primarily purified salvia miltiorrhiza extract is taken as the converted raw material, thus not only removing the metal ions which are not beneficial to conversion but also removing most colloid-like impurities and frontal impurities which are not beneficial to following separation of the salvianolic acid; and the directional conversion rate of the salvianolic acid B to the salvianolic acid A prepared by the method is not less than 10% and even reaches 60%.
Owner:SUZHOU LEINA PHARMA RES DEV +1
Method for increasing contents of tanshinone and salvianolic acid in salvia miltiorrhiza hairy root by using transgene AtMYC2
InactiveCN104726485AIncrease contentGood effectFermentationVector-based foreign material introductionSalvianolic acidBiology
The invention relates to a method for increasing the contents of tanshinone and salvianolic acid in a salvia miltiorrhiza hairy root by using a transgene AtMYC2, belonging to the technical field of gene engineering. The method comprises the steps of constructing a high-efficiency expression vector of a plant by using an arabidopsis transcription factor AtMYC2, and carrying out genetic transformation on salvia miltiorrhiza leaves to obtain a gene AtMYC2 overexpressed transgenetic salvia miltiorrhiza hairy root; analyzing the expression of AtMYC2 in the transgenetic salvia miltiorrhiza hairy root and related genes in biosynthetic pathways of tanshinone and salvianolic acid through qRT-PCR; measuring the contents of tanshinone and salvianolic acid in the transgenetic salvia miltiorrhiza hairy root by using a high-performance liquid chromatography (HPLC); and measuring the antioxidant activity of tanshinone and salvianolic acid in the transgenetic salvia miltiorrhiza hairy root by using a DPPH free radical scavenging method. The invention provides the method for simultaneously increasing the contents of tanshinone and salvianolic acid in salvia miltiorrhiza hairy root and also provides a novel high-quality raw material for producing tanshinone and salvianolic acid with important clinic demands so as to have the positive promoting significance and application value for relieving the problem that the drug resources of tanshinone and salvianolic acid are short.
Owner:SHANGHAI NORMAL UNIVERSITY
Transgenic method for improving salvianolic acid B content in root of red-rooted salvia
InactiveCN102061297AIncreased salvianolic acid B contentComponent separationMicrobiological testing/measurementSalvianolic acid BBiology
The invention discloses a transgenic method for improving salvianolic acid B content in root of red-rooted salvia, which comprises the following steps of: obtaining cDNA overall length of arabidopsis anthocyanidin generation transcription factor 1 gene through gene cloning; constructing a plant expression vector containing the genes; transforming agrobactrium tumefaciens EHA105 by using the vector so as to obtain an agrobactrium tumefaciens strain containing the genes; transforming the root of red-rooted salvia by using the agrobactrium tumefaciens strain, and culturing to obtain a transgenicplant of the root of red-rooted salvia detected through a polymerase chain reaction; detecting the expression of the arabidopsis anthocyanidin generation transcription factor 1 gene in the transgenicroot of red-rooted salvia through a semi-quantitative reverse transcription-polymerase chain reaction; and performing high performance liquid chromatography on the salvianolic acid B content in the transgenic root of red-rooted salvia subjected to the gene expression, and screening to obtain a transgenic plant of the root of red-rooted salvia with the improved salvianolic acid B content. Due to the obtained transgenic plant of the root of red-rooted salvia, the salvianolic acid B content is 73.27mg / g in dry roots when the transgenic plant of the root of red-rooted salvia grows for 165 days, wherein the salvianolic acid B content is two times of the salvianolic acid B content in non-transformed common dry roots of the root of red-rooted salvia.
Owner:SHAANXI NORMAL UNIV
Method for preparing salvianolic acid A of salvia miltiorrhiza
InactiveCN102219685AOrganic compound preparationCarboxylic acid esters preparationSalvianolic acid KGradient elution
The invention discloses a method for extracting salvianolic acid A, which is characterized in that a new process method is adopted to obtain salvianolic acid A extract, the yield of the salvianolic acid A in the salvianolic acid A extract prepared with the method is more than five thousandth, thus saving a great quantity of resources. The invention further discloses a method for preparing the salvianolic acid A, which comprises the steps of adopting a medium pressure liquid phase preparation method, wherein eluent has two phases to carry out isocratic or gradient elution to obtain high-purity salvianolic acid A with related substances, such as salvianolic acid F and salvianolic acid C, with content lower than 0.5 percent. The quality of the salvianolic acid A obtained by using the method is more uniform and more stable.
Owner:PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
Method for preparing salvianolic acid A
ActiveCN103242161APrevent oxidationLow impurity contentOrganic compound preparationCarboxylic acid esters preparationSalvianolic acid KSalvianolic acid B
The invention discloses a method for preparing salvianolic acid A. The method comprises the following steps of: (1), with a substance containing salvianolic acid B as a material, adding an acid substance with weight 0.1-10 times that of the raw material and concentration of 0.01%(v / v)-100%(v / v); adding an organic solvent with weight 0.01-10 times that of the acid substance and boiling point higher than 100 DEG C; heating for 3-5 hours at the temperature of 110-130 DEG C to obtain salvianolic acid A enrichment liquid, wherein the salvianolic acid B accounts for 2%-100% by weight in the substance containing the salvianolic acid B; and (2), cooling the salvianolic acid A enrichment liquid, adding water which is 2-6 times of the enrichment liquid to dilute and purifying to obtain the salvianolic acid A. The method for preparing salvianolic acid A can be used for preventing the salvianolic acid A from oxidizing in a high-temperature aqueous solution, improving the conversion rate of the salvianolic acid B substance, and achieving the material extracting rate of 20%-60%. Meanwhile, the impurity content and purifying difficulty of the final product salvianolic acid A are lowered, so that the prepared salvianolic acid A has purity higher than 90% and can be used for carrying out industrial production well.
Owner:CHENGDU KEYUAN BIOTECH
Method for effective preparation of salvianolic acid B extract
ActiveCN103923043AHigh salvianolic acid B contentImprove physiological activityOrganic chemistryAlcohol contentSalvianolic acid B
The invention discloses a method for effective preparation of a salvianolic acid B extract. The method comprises the steps of: (1) taking Salvia Miltiorrhiza dregs extracted by a 80-100% ethanol solution, adding an ethanol solution with a pH value of 2-8 and an alcohol content of 30-60% to conduct extraction so as to obtain an extracted solution; (2) concentrating the extracted solution to obtain a concentrated solution, and conducting cooling; (3) subjecting the concentrated solution to acid precipitation, carrying out low-temperature standing and solid-liquid separation, thus obtaining a liquid; (4) separating and purifying salvianolic acid B by column chromatography; and (5) carrying out concentration and drying to obtain the salvianolic acid B extract.
Owner:TIANJIN TASLY MORDEN TCM RESOURCES
An extracting, separating and purifying method of salvianolic acid A and a preparing method of salvianolic acid salts
InactiveCN105523926AEasy to prepareSimple and time-saving preparation methodOrganic compound preparationCarboxylic acid esters separation/purificationMagnesium saltPolyamide
The invention relates to an extracting, separating and purifying method of salvianolic acid A and a preparing method of salvianolic acid A salts. The extracting, separating and purifying method adopts salvia miltiorrhiza bunge var.alha or danshen root as a raw material and includes steps of solvent extraction, solvent extraction, concentration for drying, separation, purification, MCI column separation, crystallization and recrystallization to obtain the salvianolic acid A. Compared with macroporous resin columns, polyamide column chromatography adopted by the extracting, separating and purifying method can purify phenolic acid components more effectively and has better purification effects. A salvianolic acid A magnesium salt complexing process is adopted, and therefore chromatographic processes using macroporous resin or polyamide column chromatography can be omitted, and the purifying method is simpler, more time-saving and lower in cost. The preparing method of the salvianolic acid A magnesium salt is simple and suitable for large-scale production. A salvianolic acid A ammonium salt is a novel salvianolic acid A salt compound.
Owner:SHANDONG UNIV
Use of salvianolic acid B
ActiveCN101496798AInhibit enzyme activityOrganic active ingredientsCardiovascular disorderSalvianolic acid BSalvianolic acid
The invention discloses application of a compound which is shown in a formula I and has a mother nucleus structure in preparing an MMP-9 enzymatic activity inhibitor. The invention also discloses a method for screening substances having the function of inhibiting the MMP-9 enzymatic activity.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Method for preparing total salvianolic acid
ActiveCN101721467APromote learning and memoryImprove hypoxia toleranceSenses disorderNervous disorderSalvianolic acid BPolyamide
The invention discloses a method for preparing total salvianolic acid. The method comprises the following steps of extracting Salvia miltiorrhiza by water-containing low-grade alcohol and extracting headspace polyamide or separating macroporous resin. The method has the advantages that the transferring rate of salvianolic acid B is high and can achieve 50-60%; the loss of active ingredients is low, the quality of the prepared product is good, the content of the total phenolic acid is equal to or greater than 80%, the content of salvianolic acid B is equal to or greater than 50%, and the therapeutic effect is obvious. The invention also discloses a preparation on pharmacy and a preparing purpose thereof.
Owner:TIANJIN TASLY ZHIJIAO PHARMA
Medicinal composition containing salvianolic acid B, total ara-saponin and camphol and its preparation and use
ActiveCN1586491AImprove extraction efficiencyReduce the temperatureOrganic active ingredientsCardiovascular disorderClinical efficacyHas active ingredient
The medicinal composition of the present invention is compound freeze dried red sage powder for injection comprising red sage extract with salvianolic acid as main component, notoginseng extract with arasaponin as main component, hydroxypropyl beta-cyclodextrin clathrate of borneol and medicinal supplementary material. The preparation process includes extracting red sage component via ultrasonic extraction, ultrafiltering, ethyl acetate extraction and concentration; extracting notoginseng component via water extraction, alcohol precipitation and macro resin adsorption; clathrating borneol to raise its water solubility; and other steps. The present invention is used in preventing and treating cardiac and cerebral vascular diseases and has obvious curative effect.
Owner:广东天之骄生命科技有限公司 +1
Method for preparing salvianolic acid A
ActiveCN103044252AGood water solubilityNot destroyedOrganic compound preparationCarboxylic acid esters preparationElutionVacuum drying
The invention relates to a method for preparing salvianolic acid A. According to the method, salvia miltiorrhiza extract is prepared from salvia miltiorrhiza medicinal materials and is subjected to vacuum drying, spray drying or microwave vacuum drying after the salvia miltiorrhiza extract is subjected to catalytic conversion and the steps of separation, elution and the like, thereby obtaining the salvianolic acid A. The method for preparing the salvianolic acid A, provided by the invention, is very applicable to industrial application, lower in production cost and novel.
Owner:JIANGZI QINGFENG PHARMACEUTICALS INC
Method for preparing total salvianolic acid
ActiveCN102091125ANo pollutionSimple stepsCardiovascular disorderPlant ingredientsSalvianolic acidEnergy consumption
The invention discloses a method for preparing total salvianolic acid and application thereof. The preparation method comprises the following steps of: impregnating root of red-rooted salvia by cold water, extracting by a diacolation process, adsorbing diacolation liquid by macroporous adsorbent resin, eluting, concentrating and drying eluent under reduced pressure to obtain the total salvianolic acid. The method for preparing the total salvianolic acid has the advantages and characteristics of simple steps, convenience for operation, high yield of finished products (which is over 5 percent generally), less energy consumption, no pollution, high safety and easiness in industrial production. The obtained total salvianolic acid can be used as medicaments for preventing and treating cardiovascular and cerebrovascular diseases and the like.
Owner:CHENGDU DIAO JIUHONG PHARMA FAB
Method for preparing total salvianolic acid
ActiveCN102091125BNo pollutionSimple stepsCardiovascular disorderPlant ingredientsSalvianolic acidEnergy consumption
Owner:CHENGDU DIAO JIU HONG PHARMACEUTICAL FACTORY
Method for improving stability of salvianolic acid B
InactiveCN105061370AReduce manufacturing costWide variety of sourcesOrganic chemistryPolyolSalvianolic acid B
The present invention provides a method for improving stability of salvianolic acid B. The method comprises the steps of: 1) preparing a low eutectic mixture, mixing dried polyol with choline quaternary ammonium salt in a molar ratio of 4-1:1, and heating with stirring at 80-100 DEG C for 6-10 h to obtain a uniform transparent liquid; 2) weighing and dissolving salvianolic acid B in the eutectic mixture, sealing and storing. The salvianolic acid B has good thermal stability (60-90 DEG C) in the eutectic mixture. The present invention overcomes the disadvantages of easy deterioration and degradation of salvianolic acid B during storage in a conventional solvent and high-temperature sterilization, and has great importance on the development and application of salvianolic acid B oral preparations.
Owner:SHANXI UNIV
Method for preparing salvianolic acid A
ActiveCN103044251ASimple preparation processReduce manufacturing costOrganic compound preparationCarboxylic acid esters preparationElutionSalvianolic acid A
The invention relates to a method for preparing salvianolic acid A. According to the method, salvia miltiorrhiza extract is prepared from salvia miltiorrhiza medicinal materials and is subjected to microwave vacuum drying after the salvia miltiorrhiza extract is subjected to catalytic conversion and the steps of separation, elution and the like. The method for preparing the salvianolic acid A, provided by the invention, is very applicable to industrial application, lower in production cost and novel.
Owner:JIANGXI KEWEI COLLABORATIVE INNOVATION PHARM CO LTD
Detection method of phenolic acid compounds in compound radix salviae miltiorrhizae tablet
InactiveCN103776908AFully reflect the qualitySimple methodComponent separationSalvianolic acid BResource saving
The invention provides a detection method of phenolic acid compounds in a compound radix salviae miltiorrhizae tablet, and the detection method comprises the following steps: preparing a standard solution, a reference solution and a to-be-tested product solution, passing through a high performance liquid chromatography for detection; then calculating a relative correction factor of the phenolic acid compounds relative to salvianic acid A sodium; and using a formula IV shown in the specification too obtain the phenolic acid compound content in the compound radix salviae miltiorrhizae tablet. According to the detection method, by detection of one compound (salvianic acid A sodium), simultaneous determination of multiple compounds (salvianic acid A, protocatechuic aldehyde, rosmarinic acid, lithospermic acid and salvianolic acid B) can be realized, and the detection method is simple, rapid, accurate, good in universality, labor, and material and financial resource saving, and can more fully reflect the quality of the compound radix salviae miltiorrhizae tablet.
Owner:GUANGZHOU BAIYUSN HUTCHISON WHAMPOA CHINESE MEDICINE
Extraction method of salvianolic acid B
InactiveCN106478565AReduce extraction and separation stepsSimple processOrganic chemistryBulk chemical productionAcid waterSalvianolic acid B
The invention provides an extraction method of salvianolic acid B. The method comprises the following steps of (1) salvia miltiorrhiza medicinal materials subjected to pretreatment are fed into a super-critical CO2 extraction device; acid water with the pH being 2 to 4 is used as an entrainer to perform super-critical extraction to obtain an extraction solution; (2) the extraction solution obtained in the step (1) is subjected to rotary evaporateion concentration until no water exists to obtain salvianolic acid B. The acid water with the pH being 2 to 4 is used as the entrainer, the salvianolic acid B in the salvia miltiorrhiza medicinal materials is directly extracted out in one step through super-critical CO2 extraction device. The method provided by the invention has the advantages that the extraction efficiency is high; no solvent residue toxicity exists; the extraction separation steps are greatly reduced; the natural active ingredients and heat-sensitive ingredients (salvianolic acid B) cannot be easily decomposed or damaged, the natural features of the extracts can be maintained to the maximum degree, and the selective separation can be realized; the extraction method can be widely applied to natural substance extraction; the problem in the prior art can be effectively avoided.
Owner:GUIZHOU JINGFENG INJECTION
Method for preparing salvianolic acid A bulk drug
ActiveCN102731308AReduce usageExtended service lifeOrganic active ingredientsNervous disorderParticulatesPolyamide
The invention relates to a preparation method for a salvianolic acid A bulk drug and its medicinal preparation. The method comprises the following steps: employing dried roots of Salvia miltiorrhiza Bge as a raw material, crushing, extracting a solvent, extracting an organic solvent, carrying out macroporous resin or polyamide resin chromatographic column chromatography, extracting the organic solvent, drying and the like to obtain the salvianolic acid A. Compared with the prior arts for preparing the salvianolic acid A, the method of the invention has the characteristics of simple process flow, low cost, high product purity, good industrial adaptability and the like. The salvianolic acid A prepared by the invention can be prepared to pharmaceutically acceptable medicinal preparation forms of tablets, capsules, particulate agents, oral liquids, dripping pills, pellets, injection and the like.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI +1
Method for preparing salvianolic acid A
ActiveCN106431915AImprove efficiencyLow costOrganic compound preparationCarboxylic acid esters preparationChromatographic separationSalvianolic acid K
The invention discloses a method for preparing salvianolic acid A. The method includes the following steps that firstly, salvianolic acid B is prepared into a solution with the concentration of 35-45 mg / mL by means of NaOH or NaHCO3 with the pH value of 3.5-4.5, the solution is placed in a subcritical water reaction kettle, after the temperature of a heating furnace reaches 170-190 DEG C and is stabilized, the reaction kettle is placed into the heating furnace, the reaction kettle is taken out after 50-70 min and placed in ice water bath or cold water to be cooled, the liquid is taken out and subjected to freeze-drying, and a crude product rich in salvianolic acid A is obtained; secondly, salvianolic acid A is separated and purified by means of high-speed countercurrent chromatography, wherein a solvent system is prepared from petroleum ether, ethyl acetate, n-butyl alcohol and water according to the ratio of 2:3:1:9, 10 mM of trifluoroacetic acid is added to an upper phase to form a stationary phase, 10 mM ammonia water is a lower phase and serves as a mobile phase, the volume of a high-speed countercurrent chromatography column is 200-400 mL, the sample loading amount is 1.0-1.2 g, the rotation speed is 600-1000 rpm, the flow speed is 1-4 mL / min, and the detection wavelength is 280 nm. The method is low in cost, easy to operate and high in efficiency, salvianolic acid crude extracts can be converted on a large scale, and a salvianolic acid A monomeric compound with the purity higher than 98% is separated and prepared.
Owner:SHANDONG ANALYSIS & TEST CENT
Method for extraction of total salvianolic acid from salvia miltrorrhiza ethanol-precipitation precipitates
InactiveCN101947254ATake advantage ofLow priceCardiovascular disorderPlant ingredientsEthanol precipitationSalvianolic acid
The invention provides a method for the extraction of total salvianolic acid from salvia miltrorrhiza ethanol-precipitation precipitates, which is characterized by adopting percolation technology to recover total salvianolic acid from from salvia miltrorrhiza ethanol-precipitation precipitates. The method comprises the steps of: at first, drying the precipitates resulted from salvia miltrorrhiza ethanol-precipitation, crushing the dry precipitates to obtain irregular particles, sieving the particles, and selecting and filling the appropriately-sized particles in a chromatography column, formulating eluant containing certain components, immersing the precipitates in the chromatography column in the eluant for a certain period of time and then implementing percolation at certain flow speed, and collecting and drying percolate to obtain the total salvianolic acid. The method has the advantages of simple and easily-controlled process, low cost of the eluant, high purity of the recovered total salvianolic acid, great suitability for the recovery of the total salvianolic acid from salvia miltrorrhiza ethanol-precipitation precipitates, and enhanced utilization rate of salvia miltrorrhiza medicinal material.
Owner:ZHEJIANG UNIV +1
Oral medicine composition containing salvianolic acid and its prepn
Owner:PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
Method for purifying salvianolic acid A
ActiveCN102993015AImprove conversion rateNot easy to saveOrganic compound preparationCarboxylic acid esters separation/purificationOrganic solventSilica gel
The invention relates to a method for purifying salvianolic acid A, which comprises the steps of: adjusting the pH of eluate or extract liquid containing salvianolic acid A to 2.5-4.5, and centrifuging; separating supernatant by non-polar or weak-polar macroporous resin column chromatography; eluting with water and then eluting with eluent; carrying out high-efficiency liquid phase detection of salvianolic acid A, and collecting eluate containing salvianolic acid A; separating the obtained eluate with a dextrane gel LH-20 or ODS-C18 or polyamide chromatographic column; eluting with eluent; carrying out high-efficiency liquid phase detection of salvianolic acid A, and collecting eluate containing salvianolic acid A; adjusting the pH of the eluate to 2.0-4.0, extracting the eluate with an organic solvent and separating the organic solvent phase; separating the obtained solution by using a silica gel chromatographic column, eluting with the eluent, carrying out high-efficiency liquid phase detection of salvianolic acid A, and collecting eluate containing salvianolic acid A; recovering the eluent at reduced pressure; and dissolving the eluate with water, and carrying out microwave vacuum drying to further purify salvianolic acid A.
Owner:JIANGZI QINGFENG PHARMACEUTICALS INC
New application of salvianolic acid A as lipoprotein-associated phospholipase A2 inhibitor
InactiveCN107296806AReduce contentReduced activityOrganic active ingredientsMetabolism disorderLipoprotein-associated phospholipase A2Balloon injury
The invention discloses new application of salvianolic acid A as lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. High-fat feeding is combined with VD3 injection and a balloon injury technique to establish a rat atherosclerosis (AS) model, and the influence of the salvianolic acid A on the Lp-PLA2 content and activity of AS rat serum and the influence of the salvianolic acid A on the Lp-PLA2mRNA of an AS rat aorta can be researched. A result shows that the salvianolic acid A can be used for lowering the Lp-PLA2 content and activity of the AS rat serum, and carrying out down regulation on the expression of aorta Lp-PLA2 protein so as to perform an anti-AS function. Meanwhile, human pancreatic cancer BxPC3 nude mouse subcutaneous transplantation tumor model is established, the influence of the SAA (SalvianolicAcid A) of two administration routes on nude mice bearing the Lp-PLA2, cPLA2 and sPLA2 expression can be researched. A result shows that the contents of the Lp-PLA2, the cPLA2 and the sPLA2 in the serum and the tumor tissues and the peri-tumorous tissues of the nude mice bearing the tumor can be obviously lowered. The new application is opened up for the salvianolic acid A, and the salvianolic acid A can be expected to serve as the Lp-PLA2 inhibitor for various medical applications.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY
Ultrasonic extraction method for salvianolic acid B
InactiveCN101544625BSimple processReduce extraction timeOrganic chemistryAntinoxious agentsAcetic acidOrganic solvent
Owner:NORTHWEST A & F UNIV
Method for purifying salvianolic acid A by adopting normal phase chromatography
InactiveCN102212005AEfficient removalImproving the Efficiency of Separating Dan A Pseudo-"Colloidal" ImpuritiesOrganic compound preparationCarboxylic acid esters preparationSeparation technologyEthyl acetate
The invention provides a method for purifying salvianolic acid A by adopting a normal phase chromatography based on physicochemical properties, chromatographic behaviors and unit separation technology adaptabilities of chemical compositions of salvia miltiorrhiza. A normal phase chromatographic packing is chromatographic silica gel the granularity of which is 100-200 meshes, wherein the normal phase chromatography comprises the following operation steps of: extracting a salvianolic acid A aqueous solution by using ethyl acetate; concentrating ethyl acetate extract liquor until the solid content is 20-30 percent; adding chromatographic silica gel in an amount which is 2-2.5 times that of the salvianolic acid A; putting into a rotatory evaporator for drying at reduced pressure to obtain a flowing solid sample; and putting the solid sample at the top end of a silica gel wet column. A produced prepared with the method has stable and controllable quality and acceptable cost.
Owner:YANTAI TARGET DRUG RES +1
Separation and purification method of salvianolic acid B and preparation method of salvianolic acid B magnesium salt
The invention relates to a separation and purification method of salvianolic acid B and a preparation method of a salvianolic acid B magnesium salt. The separation and purification method of the salvianolic acid B comprises taking a medicinal material of danshen root or white flower danshen as a raw material, and carrying out the steps of solvent extraction, separation and purification through a magnesium salt complexing method, MCI column purification, crystallization and recrystallization. According to the methods provided by the invention, a salvianolic acid B magnesium salt complexing method is adopted, so that a chromatography process with macroporous adsorption resin or polyamide column chromatography can be saved, the purification method is simpler and more time-saving, and the cost is lower. The preparation method of the salvianolic acid B magnesium salt is simple, and is low in cost, high in yield, and high in purity which can reach 98%, so that the preparation method is more suitable for mass production.
Owner:SHANDONG UNIV
Medicinal application of salvianolic acid A
InactiveCN106619598AInhibit aggregationExcellent anti-platelet aggregation effectOrganic active ingredientsNervous disorderAdenosineBlood plasma
The invention relates to the technical field of medicines, discloses novel application of salvianolic acid A, and particularly the application of salvianolic acid A in preparing a medicine for increasing content of CAMP (Cyclic Adenosine Monophosphat) in thrombocyte and / or blood plasma, a medicine for inhibiting activity of phosphodiesterase in thrombocyte, a medicine for promoting activity of adenylate activating enzymes, and a medicine for inhibiting concentration of platelet cytoplasmic calcium, particularly a medicine for preventing or treating thrombolysis and myocardial Ischemia reperfusion injury caused by percutaneous coronary intervention operation or coronary artery bypass grafting and the like.
Owner:威海恒基伟业信息科技发展有限公司
Pharmaceutical composition of hydroxysafflor yellow A and salvianolic acid A, and kit
InactiveCN104771389AIncrease contentReduce impurityOrganic active ingredientsCardiovascular disorderMedicineCurative effect
The invention relates to a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, specifically to a pharmaceutical composition of hydroxysafflor yellow A and salvianolic acid A, and a kit. The pharmaceutical composition for treating cardiovascular and cerebrovascular diseases comprises hydroxysafflor yellow A and salvianolic acid A. According to the invention, a compound preparation prepared from the hydroxysafflor yellow A and salvianolic acid A monomer or combined appilication of the hydroxysafflor yellow A and salvianolic acid A monomer enables the content of effective components to be effectively increased and impurities in commercially available products to be eliminated, so the current situation that the commercially available products obviously incur anaphylactic reaction is greatly improved. The pharmaceutical composition provided by the invention has substantial curative effect and is applicable to clinical application.
Owner:ZHEJIANG YONGNING PHARMA
Salvianolic acid A tablet and application thereof to medicine preparation
ActiveCN103142572AOrganic active ingredientsOrganic compound preparationSalvianolic acid BIschemic Heart Diseases
The invention relates to application of a salvianolic acid A tablet to preparation of medicine for preventing and treating ischemic heart disease. The salvianolic acid A tablet comprises by weight 5%-60% of a salvianolic acid A composition, 90%-35% of a filler, 2%-10% of a disintegrant and 0.1%-0.5% of a lubricant. The salvianolic acid A composition comprises salvianolic acid A more than 93% and less than 100%, and other 4 ingredients including 0.1%-2% of alkannic acid, 0.1%-2% of rosmarinic acid, 0.1%-2% of salvianolic acid B and 0.1%-2% of salvianolic acid C.
Owner:JIANGZI QINGFENG PHARMACEUTICALS INC
Preparation process of total salvianolic acid
ActiveCN1810270BHigh yieldSimple stepsCardiovascular disorderPlant ingredientsSalvianolic acid KVascular disease
Owner:CHENGDU DIAO JIUHONG PHARMA FAB
Popular searches
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com